Martin Investment Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $227K | Buy |
2,906
+36
| +1% | +$2.9K | 0.08% | 46 |
|
|
2026
Q1 | $249K | Sell |
2,870
-880
| -23% | -$84.3K | 0.07% | 44 |
|
|
2025
Q4 | $360K | Sell |
3,750
-1,913
| -34% | -$186K | 0.1% | 41 |
|
|
2025
Q3 | $539K | Buy |
5,663
+100
| +2% | +$9.19K | 0.14% | 39 |
|
|
2025
Q2 | $485K | Buy |
5,563
+860
| +18% | +$72.9K | 0.12% | 39 |
|
|
2025
Q1 | $423K | Hold |
4,703
| – | – | 0.11% | 40 |
|
|
2024
Q4 | $376K | Sell |
4,703
-15
| -0.3% | -$1.3K | 0.1% | 40 |
|
|
2024
Q3 | $425K | Buy |
4,718
+5
| +0.1% | +$421 | 0.1% | 40 |
|
|
2024
Q2 | $371K | Hold |
4,713
| – | – | 0.1% | 43 |
|
|
2024
Q1 | $411K | Sell |
4,713
-9,125
| -66% | -$779K | 0.1% | 41 |
|
|
2023
Q4 | $1.14M | Buy |
13,838
+998
| +8% | +$76.1K | 0.34% | 29 |
|
|
2023
Q3 | $1.01M | Sell |
12,840
-205
| -2% | -$17.2K | 0.3% | 32 |
|
|
2023
Q2 | $1.15M | Buy |
13,045
+160
| +1% | +$13.8K | 0.32% | 34 |
|
|
2023
Q1 | $1.04M | Hold |
12,885
| – | – | 0.3% | 35 |
|
|
2022
Q4 | $1M | Buy |
12,885
+3,280
| +34% | +$266K | 0.31% | 33 |
|
|
2022
Q3 | $776K | Sell |
9,605
-180
| -2% | -$16.2K | 0.27% | 33 |
|
|
2022
Q2 | $878K | Hold |
9,785
| – | – | 0.25% | 36 |
|
|
2022
Q1 | $1.09M | Buy |
9,785
+3,467
| +55% | +$366K | 0.28% | 34 |
|
|
2021
Q4 | $654K | Sell |
6,318
-6,157
| -49% | -$713K | 0.16% | 41 |
|
|
2021
Q3 | $1.56M | Buy |
12,475
+85
| +0.7% | +$11K | 0.39% | 35 |
|
|
2021
Q2 | $1.54M | Hold |
12,390
| – | – | 0.4% | 36 |
|
|
2021
Q1 | $1.46M | Buy |
12,390
+6,157
| +99% | +$722K | 0.41% | 35 |
|
|
2020
Q4 | $730K | Buy |
6,233
+2
| +0% | +$220 | 0.23% | 38 |
|
|
2020
Q3 | $648K | Buy |
6,231
+2,798
| +82% | +$281K | 0.23% | 36 |
|
|
2020
Q2 | $315K | Sell |
3,433
-139
| -4% | -$13.3K | 0.13% | 39 |
|
|
2020
Q1 | $322K | Buy |
3,572
+25
| +0.7% | +$2.66K | 0.16% | 38 |
|
|
2019
Q4 | $402K | Sell |
3,547
-195
| -5% | -$21.4K | 0.14% | 37 |
|
|
2019
Q3 | $406K | Hold |
3,742
| – | – | 0.1% | 37 |
|
|
2019
Q2 | $364K | Buy |
3,742
+80
| +2% | +$7.3K | 0.09% | 37 |
|
|
2019
Q1 | $334K | Sell |
3,662
-50
| -1% | -$4.47K | 0.09% | 37 |
|
|
2018
Q4 | $338K | Sell |
3,712
-3,290
| -47% | -$307K | 0.11% | 35 |
|
|
2018
Q3 | $689K | Sell |
7,002
-9
| -0.1% | -$832 | 0.19% | 33 |
|
|
2018
Q2 | $600K | Hold |
7,011
| – | – | 0.15% | 33 |
|
|
2018
Q1 | $562K | Buy |
7,011
+180
| +3% | +$14.8K | 0.14% | 34 |
|
|
2017
Q4 | $531K | Hold |
6,831
| – | – | 0.15% | 33 |
|
|
2017
Q3 | $531K | Hold |
6,831
| – | – | 0.15% | 33 |
|
|
2017
Q2 | $606K | Sell |
6,831
-41,024
| -86% | -$3.46M | 0.17% | 31 |
|
|
2017
Q1 | $3.85M | Sell |
47,855
-75,471
| -61% | -$5.9M | 1.09% | 33 |
|
|
2016
Q4 | $8.79M | Sell |
123,326
-15
| -0% | -$1.18K | 1.67% | 36 |
|
|
2016
Q3 | $10.7M | Buy |
123,341
+5,370
| +5% | +$468K | 1.76% | 29 |
|
|
2016
Q2 | $10.2M | Buy |
117,971
+36,182
| +44% | +$2.93M | 1.71% | 28 |
|
|
2016
Q1 | $6.13M | Hold |
81,789
| – | – | 0.96% | 32 |
|
|
2015
Q4 | $6.29M | Buy |
81,789
+24,332
| +42% | +$1.83M | 1% | 32 |
|
|
2015
Q3 | $3.85M | Hold |
57,457
| – | – | 0.62% | 35 |
|
|
2015
Q2 | $4.26M | Buy |
57,457
+60
| +0.1% | +$4.58K | 0.61% | 32 |
|
|
2015
Q1 | $4.48M | Buy |
+57,397
| New | +$4.35M | 0.62% | 33 |
|
Other funds holding MDT
LMFP
FWIA
SRIM
DC
CAI
ETC
Martin Investment Management's MDT Position: Q2 2026 in Review
Martin Investment Management increased its Medtronic (MDT) stake by 1.3% in Q2 2026, buying an estimated $2.9K and bringing the position to 2,906 shares worth $227K. The position accounts for 0.08% of the portfolio, ranked #46.
Martin Investment Management first reported a position in MDT in Q1 2015 and has held it in 46 quarters since. The position peaked at $10.7M in Q3 2016. 626 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Martin Investment Management held 2,906 shares of Medtronic worth $227K as of Q2 2026.
- Martin Investment Management bought 36 Medtronic shares in Q2 2026, an estimated $2.9K.
- Medtronic made up 0.08% of Martin Investment Management's portfolio in Q2 2026, its #46 holding.
- Martin Investment Management first reported a position in Medtronic in Q1 2015 and has held it in 46 quarters since.
- Martin Investment Management's Medtronic position peaked at $10.7M in Q3 2016.
- 626 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Martin Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.